Kuria Therapeutics, Inc.
Developing novel NRF2 activators to improve mitochondrial function, resolve oxidative stress, and suppress inflammation in diseases of the eye and skin.
)
January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)